Nektar Therapeutics (NKTR) Misses Q1 EPS by 182c
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $72.74 --0%
Revenue Growth %: -11.4%
Financial Fact:
Provision for income taxes: 139K
Today's EPS Names:
VIVO, PMCB, PLCE, More
Revenue Growth %: -11.4%
Financial Fact:
Provision for income taxes: 139K
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q1 EPS of ($1.82). Revenue for the quarter came in at $10.9 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Campbell Soup (CPB) Reports In-Line Q4 EPS, Misses on Revenue; Offers FY27 EPS Guidance
- Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c
- Equity Bancshares to acquire Iowa's Lincoln Bancorp for $123.8M
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
